Literature DB >> 33191141

Meta-Analysis of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.

Gang Liu1, Ming Long1, Xun Hu1, Cheng-Heng Hu2, Zhi-Min Du3.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is common in heart failure with preserved ejection fraction (HFpEF); However, the prognostic impact of AF on HFpEF patients has not been fully elucidated.
METHODS: A literature search of the PubMed and EMBASE databases on literature published through April 2019 was undertaken. Combined hazard ratio (HR) estimates and 95% confidence intervals (CIs) were calculated using fixed-effects or random-effects models, depending on the heterogeneity. Subgroup analyses, sensitivity analysis and meta-regression analyses were also performed.
RESULTS: Fourteen (14) eligible studies with 1,948,923 patients with HFpEF were included in the analysis. Atrial fibrillation was associated with an 11% increased risk of all-cause mortality in patients with HFpEF (HR 1.11, 95% CI 1.09-1.12). Sensitivity analysis confirmed the stability of the results. The stratification of studies by controlled or uncontrolled confounding factors affected the final estimate (confounder-controlled HR 1.21, 95% CI 1.12-1.30; confounder-uncontrolled HR 1.13, 95% CI 0.96-1.31). In addition, AF was an independent predictor of hospitalisation for heart failure (HR 1.32, 95% CI 1.15-1.52), cardiovascular death (HR 1.38, 95% CI 1.01-1.89) and stroke (HR 1.87, 95% CI 1.54-2.27).
CONCLUSIONS: Atrial fibrillation was associated with worse clinical outcomes in patients with HFpEF. Further investigation is required to see whether AF is the primary offender in these patients or merely a bystander to worse diastolic function.
Copyright © 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Meta-analysis; Mortality; Preserved LVEF

Year:  2020        PMID: 33191141     DOI: 10.1016/j.hlc.2020.10.010

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  4 in total

1.  Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.

Authors:  Christophe Beauloye; Anne-Catherine Pouleur; Sibille Lejeune; Clotilde Roy; Alisson Slimani; Agnès Pasquet; David Vancraeynest; Jean-Louis Vanoverschelde; Bernhard L Gerber
Journal:  Cardiovasc Diabetol       Date:  2021-02-19       Impact factor: 9.951

2.  The "Obesity Paradox" in Patients With HFpEF With or Without Comorbid Atrial Fibrillation.

Authors:  Linjuan Guo; Xiao Liu; Peng Yu; Wengen Zhu
Journal:  Front Cardiovasc Med       Date:  2022-01-11

3.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17

4.  Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.

Authors:  Min Liang; Bo Bian; Qing Yang
Journal:  Clin Cardiol       Date:  2022-01-18       Impact factor: 2.882

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.